Navigation Links
Monsanto Executives to Discuss Company's Growth Drivers, Profit Goals at Investor Conferences in February
Date:2/4/2009

ST. LOUIS, Feb. 4 /PRNewswire-FirstCall/ -- On the heels of a strong start to fiscal 2009, Monsanto Company (NYSE: MON) executives will explain to investors this month where the company sees its opportunities for continued growth through the rest of this year and how it plans to achieve its goal of more than doubling its fiscal 2007 gross profit level by fiscal 2012.

Terry Crews, chief financial officer, and Carl Casale, executive vice president of strategy and operations, will address investors in separate presentations at two conferences later this month. Both Monsanto executives will provide an update on the company's business performance and expectations, strategic initiatives, product performance, research-and-development pipeline, and other business matters at these conferences:

Tuesday, February 10, 2009 - Terry Crews will be presenting at the Goldman Sachs 13th Annual Agricultural Biotech Forum in New York. Crews' presentation will begin at 2:30 p.m. eastern time.

Wednesday, February 18, 2009 - Carl Casale will be presenting at the 2009 Morgan Stanley Global Basic Materials Conference, also in New York. Casale's presentation will begin at 12:15 p.m. eastern time.

Presentation slides and simultaneous audio webcasts of the conference calls may be accessed by visiting the company's web site at http://www.monsanto.com/investors. Following the live broadcasts, Monsanto will archive the presentation slides and replays of the webcasts at the company's web site.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. Monsanto remains focused on enabling both small-holder and large-scale farmers to produce more from their land while conserving more of our world's natural resources such as water and energy. To learn more about our business and our commitments, please visit: www.monsanto.com.

Contact: Justin Gioia (314-694-4003)


'/>"/>
SOURCE Monsanto Company
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Monsanto Company Signs Share Subscription Agreement With Devgen
3. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
4. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
5. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
6. Science Magazine Recognizes Monsanto as Top Employer
7. Monsanto Company Executives Adopt 10b5-1 Trading Plans
8. Monsanto and Devgen Describe New Approach to Insect-Protection
9. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
10. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
11. Monsanto Executives to Address Investor Conferences in February
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , ... December 01, 2016 , ... ... long-term client Nanowear on their recent FDA Class II 510(k) clearance for their ... significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. ...
(Date:12/2/2016)... bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the Company,s newest ... members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited ... introduce the INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... Nov. 30, 2016 Biotest Pharmaceuticals Corporation (BPC), ... to announce the addition of its newest plasma collection ... Nebraska . The 15,200 square foot state-of-the-art facility ... 2016 and brings the total number of BPC,s plasma ... Carlisle , BPC,s Chief Executive Officer said "We are ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
Breaking Biology Technology:
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):